Bora Pharmaceuticals Co Ltd (TPE:6472)
NT$ 455 +9.5 (+2.13%) Market Cap: 58.04 Bil Enterprise Value: 72.75 Bil PE Ratio: 36.07 PB Ratio: 3.97 GF Score: 85/100

Q2 2026 BORA PHARMACEUTICALS CO., LTD. Earnings Presentation Transcript

Aug 13, 2026 / 12:00 AM GMT
Release Date Price: NT$409 (-3.08%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

6472.TW - BORA PHARMACEUTICALS CO., LTD.
Q2 2026 BORA PHARMACEUTICALS CO., LTD. Earnings Presentation
Aug 14, 2026 / 12:00AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
The conference call will begin in thirty seconds.

Welcome, everyone.

Thank you for standing by for Bora Pharmaceuticals second quarter 2026 earnings conference call.

Today, we have Bora Pharmaceuticals Group CEO and Chairman Bobby Sheng, CFO Alice Huang with us.

All participants are in a listen-only mode. After the speaker presentations, there will be a question-and-answer session. To ask a question during the session, please click on the Q&A button on the top bar and type your question directly into the Q&A box. Some of the statements that we make today regarding our business, operations and financial performance may be considered forward-looking. Such
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot